Effects of ingesting [13C]glucose early or late into cold exposure on substrate utilization.
One of the factors limiting the oxidation of exogenous glucose during cold exposure may be the delay in establishing a shivering steady state (approximately 60 min), reducing glucose uptake into skeletal muscle. Therefore, using indirect calorimetry and isotopic methodologies in non-cold-acclimatized men, the main purpose of this study was to determine whether ingesting glucose at a moment coinciding with the maximal shivering intensity could increase the utilization rate of the ingested glucose. (13)C-enriched glucose was ingested (800 mg/min) from the onset (G0) or after 60 min (G60) of cold exposure when the thermogenic rate was stabilized to low-intensity shivering (approximately 2.5 times resting metabolic rate). For the same quantity of glucose ingested, the oxidation rate of exogenous glucose was 35% higher in G60 (159+/-17 vs. 118+/-17 mg/min in G0) between minutes 60 and 90. By the end of cold exposure, exogenous glucose oxidation was significantly greater in G0, reaching 231+/-14 mg/min, approximately 15% higher than the only rates previously reported. This considerably reduced the utilization of endogenous reserves over time and compared with the G60 condition. This study also demonstrates a fall in muscle glycogen utilization, when glucose was ingested from the onset of cold exposure (from approximately 150 to approximately 75 mg/min). Together, these findings indicate the importance of ingesting glucose immediately on exposure to a cold condition, relying on shivering thermogenesis and sustaining that consumption for as long as possible. This substrate not only provides an auxiliary fuel source for shivering thermogenesis, but, more importantly, preserves the limited endogenous glucose reserves.
Blondin
Denis P
DP
Institut de Recherche de l'Hôpital Montfort, Faculty of Health Sciences, University of Ottawa, 125 Univ. St., Ottawa, Ontario, Canada K1N 6N5.
Péronnet
François
F
Haman
François
F
D000284:Administration, Oral; D000328:Adult; D001628:Beverages; D001786:Blood Glucose / Q000378:metabolism*; D001833:Body Temperature Regulation; D002153:Calorimetry, Indirect; D002247:Carbon Isotopes; D003080:Cold Temperature; D018592:Cross-Over Studies; D004734:Energy Metabolism; D005947:Glucose / Q000008:administration & dosage* / Q000378:metabolism*; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism*; D010084:Oxidation-Reduction; D012768:Shivering; D013997:Time Factors
D001786:Blood Glucose; D002247:Carbon Isotopes; D006003:Glycogen; D005947:Glucose